Virtual Incision Secures $18 Million

Robotics startup Virtual Incision completed $18 million in Series B financing, led by SinoPharm Capital and Bluestem Capital, with participation from PrairieGold Venture Partners.

Virtual Incision’s in vivo mini-robot surgery is used for minimally-invasive colon resection and other abdominal procedures. A mini-robot is inserted into the insufflated abdomen via a small umbilical incision, after which the robot arms are manipulated at the nearby surgeon console.

According to the company, this financing will be used to support the company’s 510(k) premarket notification submission to the U.S. Food and Drug Administration.